Acorda Therapeutics, Inc. Annual Costs and Expenses in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Acorda Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
  • Acorda Therapeutics, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $39.9M, a 18.3% increase year-over-year.
  • Acorda Therapeutics, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $389M, a 162% increase year-over-year.
  • Acorda Therapeutics, Inc. annual Costs and Expenses for 2023 was $383M, a 149% increase from 2022.
  • Acorda Therapeutics, Inc. annual Costs and Expenses for 2022 was $154M, a 26% decline from 2021.
  • Acorda Therapeutics, Inc. annual Costs and Expenses for 2021 was $208M, a 9.93% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $383M +$229M +149% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $154M -$54.2M -26% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $208M -$22.9M -9.93% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $231M -$273M -54.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $504M +$71.1M +16.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $433M -$388M -47.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 $821M +$266M +47.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $556M +$96.9M +21.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $459M +$93.6M +25.6% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
2014 $365M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.